Tracking the turning point in Alzheimer’s disease
Science · 30.04.2026 · 392 (6797) · 468-469
DOI: 10.1126/science.aeb6987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 30.04.2026. Verfasst von Bart De Strooper und 1 weiteren Autor:innen. Beteiligte Einrichtung: Leuven Brain Institute, University of Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, tau Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
A blood biomarker reveals the mechanistic shift from amyloid to tau pathology
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Leuven Brain Institute, University of Leuven, Leuven, Belgium.
- Center for Brain and Disease Research, VIB, Leuven, Belgium.
- UK Dementia Research Institute, University College London, London, UK.
- Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden.
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Zitieren
APA
De Strooper, B., & Zetterberg, H. (2026). Tracking the turning point in Alzheimer’s disease. Science, 392(6797), 468-469. https://doi.org/10.1126/science.aeb6987
Vancouver
De Strooper B, Zetterberg H. Tracking the turning point in Alzheimer’s disease. Science. 2026;392(6797):468-469. doi:10.1126/science.aeb6987
BibTeX
@article{DeStrooper2026,
author = {De Strooper, Bart and Zetterberg, Henrik},
title = {Tracking the turning point in Alzheimer’s disease},
journal = {Science},
year = {2026},
volume = {392},
number = {6797},
pages = {468--469},
doi = {10.1126/science.aeb6987}
}
EUVIMED